Mineralys Therapeutics (MLYS) is down -13.9%, or -$6.14 to $38.15.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLYS:
- Mineralys Therapeutics price target raised to $56 from $52 at H.C. Wainwright
- Mineralys Therapeutics’ Earnings Call Highlights Positive Outlook
- Mineralys Therapeutics Reports Q3 2025 Financial Results
- Mineralys Therapeutics files automatic mixed securities shelf
- Mineralys Therapeutics reports Q3 EPS (52c), consensus (61c)